about
MicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signalingThe miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionThe Promise and Challenge of Therapeutic MicroRNA Silencing in Diabetes and Metabolic DiseasesmicroRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentsiRNA Versus miRNA as Therapeutics for Gene SilencingMicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics'Micro-managers' of hepatic lipid metabolism and NAFLDMicromanaging abdominal aortic aneurysmsThe role of microRNA in head and neck cancer: current knowledge and perspectivesFibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse modelsMicroRNAs in the Stressed Heart: Sorting the Signal from the NoiseFrom evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transportMicroRNAs as therapeutic targets and biomarkers of cardiovascular diseaseNeedles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulomeBeyond the genome: epigenetic mechanisms in lung remodelingConsumption of distinct dietary lipids during early pregnancy differentially modulates the expression of microRNAs in mothers and offspringMicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal CancersmiR-155: A Novel Target in Allergic AsthmamiRNAs in the Pathogenesis of Systemic Lupus ErythematosusTurning 21: Induction of miR-21 as a Key Switch in the Inflammatory ResponseMicroRNAs in cardiovascular disease: an introduction for cliniciansNetwork Topology Analysis of Post-Mortem Brain Microarrays Identifies More Alzheimer's Related Genes and MicroRNAs and Points to Novel Routes for Fighting with the DiseaseFit for the Eye: Aptamers in Ocular DisordersmiR-30 Family Controls Proliferation and Differentiation of Intestinal Epithelial Cell Models by Directing a Broad Gene Expression Program That Includes SOX9 and the Ubiquitin Ligase PathwayAkt: A Therapeutic Target in Hepatic Ischemia-Reperfusion Injury.Hypothesis of K+-Recycling Defect Is Not a Primary Deafness Mechanism for Cx26 (GJB2) DeficiencyAn miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistronMicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: results from clinical data set and patients' samplesMicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasisUp-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthaseMicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.Small RNA overcomes the challenges of therapeutic targeting of microsomal triglyceride transfer proteinGenetic variation in the 3'-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance.Identification of miRNomes associated with adult neurogenesis after stroke using Argonaute 2-based RNA sequencingMicroRNAs expression profiles in cardiovascular diseases.Exosomes-Based Gene Therapy for MicroRNA Delivery.microRNAs of parasitic helminths - Identification, characterization and potential as drug targets.MiRNA-181a regulates Toll-like receptor agonist-induced inflammatory response in human fibroblasts.Concise review: new frontiers in microRNA-based tissue regeneration.MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes.
P2860
Q26740198-CB3C8B7F-31E5-49CF-8209-847219E6C8F1Q26744831-BA22E12D-89B5-4A21-AF47-04B6C01F1750Q26750496-5841AB26-2645-45CE-848D-73462456DC45Q26778918-5A81CFFE-98BA-48FF-9389-57375E2BAAE6Q26786876-F69EBFD2-F683-4E8D-9DAD-6A32FA2DCF2BQ26796668-8504DBBB-64AC-4F49-B567-3A16A32A26C8Q26801228-007DBE0E-4567-42DD-8745-03501A6E37E5Q26823361-8E6B2FAD-541C-4623-863B-7B288B66CE7EQ26851256-A7572300-6512-42A1-99F8-0EFB398FD4CBQ26994661-4E353FB2-6382-4179-95F2-3EFB74546C13Q26995334-890FBA08-F133-4932-B327-37E5A5FD96FAQ26997647-2C7BD600-369B-4DAD-B250-1A2146848096Q27012405-9D090C47-5257-4D9E-89D3-4FD2333C1D58Q27015035-B1436A25-5766-4FDA-9CB6-4A732B204672Q27021767-58E28E6B-C4D3-4DF5-B49F-9043BA4CA9CCQ27315093-81777D52-F28A-4713-831E-B8DEB4C48EF5Q28076754-819E2C91-24C3-468E-B435-083D129269A3Q28077478-B3557206-32CF-4899-941E-D910878FAFEDQ28083028-613CD478-D45A-4118-9061-C87B4278C331Q28083164-D8E575D7-A70D-4A97-90EE-F86FB2931D79Q28084229-DA67F9C4-8197-48A5-B44D-B68FB8149377Q28552595-5B5F02C8-6A4F-4A24-B0ED-A08DA7834B68Q28828283-10129E4C-113B-45A2-AE72-D727327DF83AQ28828459-EE48371D-524E-45FE-ADC6-A2A8A648BF38Q30248771-52F6E025-480F-4DE8-A6FB-1543C692A82EQ30354613-1E4FC524-842B-4D73-876F-23FE9A4BF9DAQ30835231-1B4C7059-24E8-4EC6-9B55-2DF53D5A7FBEQ30859743-D568987C-B660-4D7D-BDA1-09654051C73FQ31132024-4ADE74BF-4CD0-4B2B-9A75-3E1E927F1FF8Q32884410-1FE83E0C-1A2F-4601-9A78-26C658CEEA32Q32884516-525ECA50-122E-454A-B7C9-17BB8B1DBB2CQ33705462-15A0FC66-2C49-4BB1-B4B3-27CD542991D7Q33708471-7706183F-9CF5-4D17-B536-D012D6D2A714Q33739701-EBBE06A6-564E-4E0E-8A75-AAD9782E6D7AQ33821302-36B4355C-8B07-4502-8057-631120545B9DQ33885485-8FAB9CB0-95CD-4454-B091-8D6F3DFB9E6FQ33892045-81E0CF44-CE2C-4AD4-B896-61C7C346C217Q33953542-0163A391-1A91-4CB8-A895-CA67C65A12C0Q33975631-80B4804E-0D8E-4576-ABDB-24E6715E923BQ34077389-F701E462-3475-45C8-8405-A8539B4DC34F
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Developing microRNA therapeutics.
@en
Developing microRNA therapeutics.
@nl
type
label
Developing microRNA therapeutics.
@en
Developing microRNA therapeutics.
@nl
prefLabel
Developing microRNA therapeutics.
@en
Developing microRNA therapeutics.
@nl
P2093
P1433
P1476
Developing microRNA therapeutics.
@en
P2093
Angela L Purcell
Arthur A Levin
Eva van Rooij
P304
P356
10.1161/CIRCRESAHA.111.247916
P577
2012-02-01T00:00:00Z